Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective

Area of Science:

• Immunology
• Oncology

Background:

• Regulatory T cells (Tregs) are crucial in immune regulation, particularly in cancer.
• Tumor-infiltrating Tregs are linked to poor cancer prognosis.
• Identifying and targeting Tregs has been challenging due to a lack of specific markers.

Purpose of the Study:

• To review the role of Tregs in anticancer immunity.
• To discuss the potential of cyclophosphamide in targeting Tregs for cancer immunotherapy.
• To explore the application of Treg-targeting strategies in cancer vaccines.

Main Methods:

• Literature review of Treg biology and function in cancer.
• Analysis of studies on cyclophosphamide's effects on Tregs.
• Examination of Treg-targeting principles for cancer immunotherapy.

Main Results:

• Tregs play a significant role in suppressing antitumor immune responses.
• Cyclophosphamide demonstrates potential as a clinical agent to suppress Tregs.
• Targeting Tregs can enhance the efficacy of cancer vaccines and other immunotherapies.

Conclusions:

• Understanding Treg subsets and their functions is critical for developing effective cancer immunotherapies.
• Cyclophosphamide offers a viable strategy to modulate Tregs and improve antitumor immunity.
• The principles of Treg targeting can be broadly applied to various cancer immunotherapy approaches.